{Reference Type}: Published Erratum
{Title}: Corrigendum: PD-1/PD-L1 immune checkpoint therapy demonstrates favorable safety profile in patients with autoimmune and cholestatic liver disease.
{Author}: Kocheise L;Piseddu I;Vonderlin J;Tjwa ET;Buescher G;Meunier L;Goeggelmann P;Fianchi F;Dumortier J;Barciela MR;Gevers TJG;Beretta-Piccoli BT;Londoño MC;Frankova S;Roesner T;Joerg V;Schmidt C;Glaser F;Sutter JP;Fründt TW;Lohse AW;Huber S;von Felden J;Sebode M;Schulze K;
{Journal}: Front Immunol
{Volume}: 15
{Issue}: 0
{Year}: 2024
{Factor}: 8.786
{DOI}: 10.3389/fimmu.2024.1369747
{Abstract}: [This corrects the article DOI: 10.3389/fimmu.2023.1326078.].